Changing the paradigm in the treatment of platinum-sensitive recurrent ovarian cancer: from platinum doublets to nonplatinum doublets and adding antiangiogenesis compounds.

Bradley J. Monk, Robert L. Coleman

Research output: Contribution to journalReview articlepeer-review

61 Scopus citations

Fingerprint

Dive into the research topics of 'Changing the paradigm in the treatment of platinum-sensitive recurrent ovarian cancer: from platinum doublets to nonplatinum doublets and adding antiangiogenesis compounds.'. Together they form a unique fingerprint.

Medicine & Life Sciences